Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men

Journal of Clinical Lipidology

Volumn 6, Issue 1, 2012, Pages 58-65

  Robinson, Jennifer G ^a   Rahilly Tierney, Catherine ^b   Lawler, Elizabeth ^b   Gaziano, J Michael ^b  

^a UNIVERSITY OF IOWA   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Blood pressure; Cardiovascular disease; Cholesterol; Elderly; Risk factors; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; BETA CAROTENE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY SURGERY; CHOLESTEROL BLOOD LEVEL; DRUG USE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PHYSICIAN; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SENESCENCE; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; VASCULAR SURGERY;

AGED; AGED, 80 AND OVER; ASPIRIN; BETA CAROTENE; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; MALE; RISK FACTORS; TREATMENT OUTCOME;

ANGINA;

EID: 84856210007     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.10.019     Document Type: Article

References (38)

1. P. Rothwell, A. Coull, and L. Silver Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) Lancet 366 2005 1773 1783 (Pubitemid 41642641)
2. A.D. Sniderman, I. Holme, and A. Aastveit Relation of age, the apolipoprotein B/apolipoprotein AI ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease Am J Cardiol 100 2007 217 221 (Pubitemid 47041986)
3. D. Goldman, D. Cutler, B. Shang, and G. Joyce The value of elderly disease prevention Forum Health Econ Policy 9 2006 Article 1
4. U.S. Census Bureau. File 2. Interim state projections of population for five-year age groups and selected age groups by sex: July, 1 2004 to 2030; 2005.
5. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
6. N.K. Wenger, S.J. Lewis, D.M. Herrington Treating to New Targets Study Steering Committee and Investigators Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease Ann Intern Med 147 2007 1 9 (Pubitemid 351664628)
7. P. Deedwania, P.H. Stone, and C.N. Bairey Merz Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease. Results of the Study Assessing Goals in the Elderly (sage) Circulation 115 2007 700 707 (Pubitemid 46294760)
8. P. Kearney, M. Whelton, K. Reynolds, P. Munter, P. Whelton, and J. He Global burden of hypertension: analysis of worldwide data Lancet 365 2005 217 223 (Pubitemid 40138015)
9. N.S. Beckett, R. Peters, A.E. Fletcher the HYVET Study Group Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 2008 1887 1898 (Pubitemid 351620109)
10. A.V. Chobanian Isolated systolic hypertension in the elderly N Engl J Med 357 2007 789 796 (Pubitemid 47295645)
11. Antiplatelet Trialists Collaboration Collaborative review of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
12. NIH State-of-the-Science Panel National Institutes of Health state-of-the-science conference statement: tobacco use: prevention, cessation, and control Ann Intern Med 145 2006 839 844
13. J.G. Robinson, G. Bakris, and J. Torner Is it time for a cardiovascular primary prevention trial in the elderly? Stroke 38 2007 441 450 (Pubitemid 46184321)
14. J.P. Mackenbach, A.E. Kunst, and H. Lautenbach Gains in life expectancy after elimination of major causes of death: Revised estimates taking into account the effect of competing causes J Epidemiol Community Health 53 1999 32 37 (Pubitemid 29012348)
15. National Center for Health Statistics. Death rates by age, sex, race, and underlying cause. United states, 1981-2004 (nmr04a).
16. M. Denke, and S. Grundy Hypercholesterolemia in the eldery Ann Intern Med 112 1990 780 792
17. R.C. Pasternak, S.C. Smith Jr., and C.N. Bairey-Merz Writing Committee Members: ACC/AHA/NHLBI clinical advisory on the use and safety of statins Circulation 106 2002 1024 1028 (Pubitemid 34925341)
18. Q. Rasheed, R. Nair, and H. Sheehan Correlation of intracoronary ultrasound plaque characteristics in atherosclerotic coronary artery disease patients with clinical variables Am J Cardiol 73 1994 753 758 (Pubitemid 24128884)
19. S.I. Chaudhry, H.M. Krumholz, and J.M. Foody Systolic hypertension in older persons JAMA 292 2004 1074 1080 (Pubitemid 39129197)
20. M.E. Mendelsohn, and R.H. Karas Molecular and cellular basis of cardiovascular gender differences Science 308 2005 1583 1587 (Pubitemid 40807497)
21. C.H. Hennekens, and K. Eberlein A randomized trial of aspirin and [beta]-carotene among U.S. Physicians Prev Med 14 1985 165 168 (Pubitemid 16203049)
22. S. Liu, Y. Song, and F.B. Hu A prospective study of the apoa1 xmni and apoc3 ssti polymorphisms in the apoa1/c3/a4 gene cluster and risk of incident myocardial infarction in men Atherosclerosis 177 2004 119 126 (Pubitemid 39361146)
23. National Cholesterol Education Panel Third Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
24. R.B. D'Agostino Sr., R.S. Vasan, and M.J. Pencina General cardiovascular risk profile for use in primary care: The Framingham Heart Study Circulation 117 2008 743 753 (Pubitemid 351640675)
25. S.M. Grundy, J.I. Cleeman, C.N.B. Merz for the Coordinating Committee of the National Cholesterol Education Program, Endorsed by the National Heart L, and Blood Institute, American College of Cardiology Foundation, and American Heart Association Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239 (Pubitemid 38924592)
26. A.V. Chobanian, G.L. Bakris, and H.R. Black The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2003 2560 2572 (Pubitemid 37430158)
27. M.J. Pencina, R.B. D'Agostino Sr., M.G. Larson, J.M. Massaro, and R.S. Vasan Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study Circulation 119 2009 3078 3084
28. S. Rosthøj, P.K. Andersen, and S.Z. Abildstrom SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data Comput Meth Prog Biomed 74 2004 69 75 (Pubitemid 38283682)
29. J.G. Robinson, and N.J. Stone Identifying patients for aggressive cholesterol lowering: the risk curve concept Am J Cardiol 98 2006 1405 1408 (Pubitemid 44666653)
30. J. Shepherd, G. Blauw, M. Murphy on behalf of the PROSPER study group Pravastatin in elderly individuals at risk of vascular disease (prosper): a randomised controlled trial Lancet 360 2002 1623 1630 (Pubitemid 35379733)
31. U. S. Preventive Services Task Force Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 150 2009 396 404
32. Steering Committee of the Physicians' Health Study Research Group Final report on the aspirin component of the ongoing Physician's Health Study N Engl J Med 321 1989 129 135
33. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979 (Pubitemid 27152782)
34. C.H. Hennekens, J.E. Buring, and J.E. Manson Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 334 1996 1145 1149 (Pubitemid 26137972)
35. D.M. Lloyd-Jones, E.P. Leip, and M.G. Larson Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 2006 791 798
36. D. Lloyd-Jones, R.J. Adams, T.M. Brown on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2010 update. A report from the American Heart Association Circulation 2009 CIRCULATIONAHA.109.192667
37. E.S. Ford, C. Li, G. Zhao, W.S. Pearson, and S. Capewell Trends in the prevalence of low risk factor burden for cardiovascular disease among united states adults Circulation 120 2009 1181 1188
38. J.M. McWilliams, E. Meara, A.M. Zaslavsky, and J.Z. Ayanian Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. Trends from 1999 to 2006 and effects of Medicare coverage Ann Intern Med 150 2009 505 515